Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study

被引:11
|
作者
Chen, Wen-jin [1 ]
Cao, Hao [2 ,3 ]
Cao, Jian-wei [4 ]
Zuo, Li [5 ]
Qu, Fa-jun [4 ]
Xu, Da [1 ]
Zhang, Hao [6 ]
Gong, Hai-yi [6 ]
Chen, Jia-xin [1 ]
Ye, Jian-qing [1 ]
Gan, Si-shun [1 ]
Zhou, Wang [1 ,4 ]
Zhu, Da-wei [5 ]
Pan, Xiu-Wu [1 ,4 ]
Cui, Xin-gang [1 ,4 ]
机构
[1] Second Mil Med Univ, Affiliated Hosp 3, Dept Urol, 700 North Moyu Rd, Shanghai 201805, Peoples R China
[2] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Peoples R China
[3] Tsinghua Univ, Peking Tsinghua Ctr Life Sci, Beijing 100084, Peoples R China
[4] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Urol, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China
[5] Nanjing Med Univ, Dept Urol, Affiliated Changzhou 2 Peoples Hosp, 29 Xinglong Rd, Changzhou 213000, Jiangsu, Peoples R China
[6] Second Mil Med Univ, Dept Orthoped Oncol, Changzheng Hosp, 415 Fengyang Rd, Shanghai 200003, Peoples R China
基金
中国国家自然科学基金;
关键词
INTRATUMORAL HETEROGENEITY; EXPRESSION; MANAGEMENT; PROTEIN;
D O I
10.1038/s41419-022-04501-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Non-clear renal cell carcinomas (nccRCCs) are less frequent in kidney cancer with histopathological heterogeneity. A better understanding of the tumor biology of nccRCC can provide more effective treatment paradigms for different subtypes. To reveal the heterogeneity of tumor microenvironment (TME) in nccRCC, we performed 10x sing-cell genomics on tumor and normal tissues from patients with papillary renal cell carcinoma (pRCC), chromophobe RCC (chrRCC), collecting duct carcinoma (CDRCC) and sarcomatoid RCC (sarRCC). 15 tissue samples were finally included. 34561 cells were identified as 16 major cell clusters with 34 cell subtypes. Our study presented the sing-cell landscape for four types of nccRCC, and demonstrated that CD8+ T cells exhaustion, tumor-associated macrophages (TAMs) and sarcomatoid process were the pivotal factors in immunosuppression of nccRCC tissues and were closely correlated with poor prognosis. Abnormal metabolic patterns were present in both cancer cells and tumor-infiltrating stromal cells, such as fibroblasts and endothelial cells. Combined with CIBERSORTx tool, the expression data of bulk RNA-seq from TCGA were labeled with cell types of our sing-cell data. Calculation of the relative abundance of cell types revealed that greater proportion of exhausted CD8+ T cells, TAMs and sarRCC derived cells were correlated with poor prognosis in the cohort of 274 nccRCC patients. To the best of our knowledge, this is the first study that provides a more comprehensive sight about the heterogeneity and tumor biology of nccRCC, which may potentially facilitate the development of more effective therapies for nccRCC.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Renal cell carcinoma: The effect of targeted therapies on clear cell and non-clear cell histologies.
    Marascio, Joseph A.
    Rabatic, Bryan M.
    Zaenger, David
    Madden, Nicholas A.
    Marchan, Edward M.
    McDermott, David
    Misiura, Anne Kathryn
    Shaaban, Sherif
    Dasher, Byron G.
    Huang, Ke
    Pishgou, Mahboubeh
    Martin, William D.
    Aletan, Maryam
    Howington, Jed W.
    Albasheer, Ahmad M.
    Amoush, Ahmad
    Stewart, John G.
    Kong, Feng-Ming
    Ferguson, Catherine L.
    Mourad, Waleed F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?
    Ismail Selvi
    Umut Demirci
    Nazan Bozdogan
    Halil Basar
    International Urology and Nephrology, 2021, 53 : 1135 - 1138
  • [43] Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?
    Selvi, Ismail
    Demirci, Umut
    Bozdogan, Nazan
    Basar, Halil
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (06) : 1135 - 1138
  • [44] Cell–cell communications shape tumor microenvironment and predict clinical outcomes in clear cell renal carcinoma
    Liu-xun Chen
    Shen-jie Zeng
    Xv-dong Liu
    Hai-bin Tang
    Jia-wu Wang
    Qing Jiang
    Journal of Translational Medicine, 21
  • [45] Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview
    Bergmann, Lothar
    Weber, Sarah
    Hartmann, Arndt
    Ahrens, Marit
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (11) : 1273 - 1286
  • [46] Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma
    Brown, Jason R.
    Calaway, Adam
    Castle, Erik
    Garcia, Jorge
    Barata, Pedro C.
    KIDNEY CANCER, 2022, 6 (01) : 53 - 68
  • [47] EFFICACY AND SAFETY OF SUNITINIB IN PATIENTS WITH NON-CLEAR CELL RENAL CELL CARCINOMA
    Lee, J. -L.
    Ahn, J. -H.
    Park, S. H.
    Lim, H. Y.
    Lee, S. H.
    Kim, T. -M.
    Cho, Y. -M.
    Song, C.
    Hong, J. H.
    Kim, C. -S.
    Ahn, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 141 - 141
  • [48] The feasibility of tumor-infiltrating lymphocyte expansion in non-clear cell renal cell carcinoma.
    Guske, Christopher
    Potez, Marine
    Miller, Justin
    Johnson, Jeffrey S.
    Ali, Johannes
    Carter, Michael
    Khambati, Fatema
    Fazili, Adnan Nazir
    Gullapalli, Keerthi
    Sexton, Wade J.
    Zemp, Logan
    Manley, Brandon J.
    Roman Souza, Gabriel
    Beatty, Matthew
    Spiess, Philippe E.
    Pilon-Thomas, Shari
    Chahoud, Jad
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [49] THE IMPACT OF NON-CLEAR CELL HISTOLOGY ON OUTCOME FOR PATIENT WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS
    Kaushik, Dharam
    Thompson, R. Houston
    Eisenberg, Manuel
    Lohse, Christine M.
    Cheville, John C.
    Leibovich, Bradley C.
    Boorjian, Stephen A.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E780 - E780
  • [50] Non-clear cell renal cell carcinoma (nccRCC): A Brazilian experience.
    Yamamura, Rosely
    Rinck, Jose A.
    Fonseca Jesus, Victor Hugo
    Tavares, Monique Celeste
    de Castro Larclprete, Ana Luisa
    Iennaco, Pietro Schettlni
    Freitas, Heleno C.
    Cunha, Isabela Warneck
    Fanelli, Marcello Ferretti
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)